Skip to main content
. Author manuscript; available in PMC: 2013 Dec 7.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Jan 19;83(1):10.1016/j.ijrobp.2011.06.1990. doi: 10.1016/j.ijrobp.2011.06.1990

Figure 5.

Figure 5

EQD2 for NSCLC cell lines treated with 2.0 Gy x 30 (top) and 10.0 Gy x 5 (bottom). Car = Carboplatin, Doc = Docetaxel, Pac = Paclitaxel, Gem = Gemcitabine, Vin = Vinorelbine. Error bars indicate 95% confidence intervals. <> denotes a significant (p<0.05) increase in EQD2 with the addition of drug using paired Student’s t-test.